- Home
- SKYH vs MIST Comparison
SKYH vs MIST Comparison
Compare SKYH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- MIST
- Stock Information
- Founded
- SKYH 2017
- MIST 2003
- Country
- SKYH United States
- MIST Canada
- Employees
- SKYH N/A
- MIST N/A
- Industry
- SKYH Military/Government/Technical
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- MIST Health Care
- Exchange
- SKYH Nasdaq
- MIST Nasdaq
- Market Cap
- SKYH 325.2M
- MIST 89.8M
- IPO Year
- SKYH N/A
- MIST N/A
- Fundamental
- Price
- SKYH $9.70
- MIST $1.89
- Analyst Decision
- SKYH Strong Buy
- MIST Strong Buy
- Analyst Count
- SKYH 3
- MIST 2
- Target Price
- SKYH $14.83
- MIST $7.50
- AVG Volume (30 Days)
- SKYH 199.9K
- MIST 595.3K
- Earning Date
- SKYH 08-12-2025
- MIST 08-07-2025
- Dividend Yield
- SKYH N/A
- MIST N/A
- EPS Growth
- SKYH N/A
- MIST N/A
- EPS
- SKYH N/A
- MIST N/A
- Revenue
- SKYH $17,950,000.00
- MIST N/A
- Revenue This Year
- SKYH $122.85
- MIST N/A
- Revenue Next Year
- SKYH $45.30
- MIST N/A
- P/E Ratio
- SKYH N/A
- MIST N/A
- Revenue Growth
- SKYH 102.32
- MIST N/A
- 52 Week Low
- SKYH $8.26
- MIST $0.63
- 52 Week High
- SKYH $14.52
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- SKYH 40.87
- MIST 67.15
- Support Level
- SKYH $9.47
- MIST $1.85
- Resistance Level
- SKYH $9.92
- MIST $2.02
- Average True Range (ATR)
- SKYH 0.31
- MIST 0.09
- MACD
- SKYH 0.05
- MIST 0.01
- Stochastic Oscillator
- SKYH 41.58
- MIST 77.50
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).